Totaro, Angelo
 Distribuzione geografica
Continente #
EU - Europa 6.243
NA - Nord America 5.187
AS - Asia 3.090
SA - Sud America 540
Continente sconosciuto - Info sul continente non disponibili 178
AF - Africa 86
OC - Oceania 11
AN - Antartide 1
Totale 15.336
Nazione #
US - Stati Uniti d'America 5.015
IT - Italia 2.786
DE - Germania 1.401
SG - Singapore 1.395
CN - Cina 700
SE - Svezia 513
BR - Brasile 421
FR - Francia 416
UA - Ucraina 307
VN - Vietnam 296
GB - Regno Unito 216
IN - India 186
IE - Irlanda 121
CA - Canada 105
NL - Olanda 91
ID - Indonesia 90
RU - Federazione Russa 81
HK - Hong Kong 80
FI - Finlandia 78
BD - Bangladesh 59
PL - Polonia 58
JP - Giappone 52
AR - Argentina 49
TR - Turchia 44
MX - Messico 41
ES - Italia 35
CH - Svizzera 31
BE - Belgio 28
IQ - Iraq 26
ZA - Sudafrica 21
PK - Pakistan 19
AT - Austria 17
KR - Corea 17
CO - Colombia 16
CI - Costa d'Avorio 15
EC - Ecuador 14
AZ - Azerbaigian 12
JO - Giordania 12
LT - Lituania 12
MY - Malesia 12
AE - Emirati Arabi Uniti 10
NG - Nigeria 10
PE - Perù 10
PH - Filippine 10
IR - Iran 9
AU - Australia 8
CL - Cile 8
EG - Egitto 8
EU - Europa 8
PY - Paraguay 8
VE - Venezuela 8
HU - Ungheria 7
MA - Marocco 7
RO - Romania 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
LB - Libano 6
PT - Portogallo 6
CR - Costa Rica 5
KE - Kenya 5
LK - Sri Lanka 5
TN - Tunisia 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NP - Nepal 4
PA - Panama 4
SN - Senegal 4
AL - Albania 3
BH - Bahrain 3
DK - Danimarca 3
GR - Grecia 3
IL - Israele 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
CG - Congo 2
CM - Camerun 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
KW - Kuwait 2
LV - Lettonia 2
MD - Moldavia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
Totale 15.144
Città #
Singapore 777
Chandler 548
Ashburn 498
San Jose 455
Rome 397
Milan 284
Jacksonville 165
Los Angeles 155
Beijing 143
Dublin 117
Ann Arbor 116
San Mateo 106
Ho Chi Minh City 105
New York 101
Nürnberg 87
Nanjing 83
Lauterbourg 80
Jakarta 79
The Dalles 77
Frankfurt am Main 72
Hanoi 72
Dearborn 71
Hong Kong 69
Munich 69
Florence 68
Hefei 63
Wilmington 63
Woodbridge 61
Nanchang 56
São Paulo 56
Boston 52
Dallas 51
Bremen 48
Houston 47
Naples 47
Tokyo 47
Bologna 45
Chicago 45
Moscow 41
Lawrence 39
Bari 38
Ottawa 38
Atlanta 34
Verona 32
Santa Clara 31
Redwood City 30
Palermo 29
Turin 29
Paris 26
Council Bluffs 25
Fairfield 25
Hyderabad 25
Seattle 25
Princeton 24
Redmond 24
Buffalo 23
Catania 23
Kraków 23
Marseille 23
Orem 22
Montreal 21
Toronto 21
Brussels 20
Helsinki 20
Izmir 20
London 20
Kent 19
Mountain View 19
Stockholm 19
Da Nang 18
Warsaw 18
Genoa 17
Cattolica 16
New Delhi 16
Phoenix 16
St Louis 16
Abidjan 15
Belo Horizonte 15
Brooklyn 15
Seoul 15
University Park 15
Augusta 14
Denver 14
Jiaxing 14
Kunming 14
Miami 14
Bexley 13
Boardman 13
Cagliari 13
Düsseldorf 13
Hebei 13
Johannesburg 13
Nuremberg 13
Shenyang 13
Amsterdam 12
Baku 12
Brescia 12
Haiphong 12
Madrid 12
Memphis 12
Totale 6.721
Nome #
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.246
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 999
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 927
E-CADHERIN AND IL-6 SERUM LEVELS IN PATIENTS AFFECTED BY PROSTATE CANCER BEFORE AND AFTER PROSTATECTOMY 440
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 361
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 329
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 328
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 320
Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis 277
Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes 256
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 255
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 218
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy 202
Patient-derived organoids in renal cell carcinoma: A review of methodologies and applications 196
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 193
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 188
[Urinary peptides and calcium oxalate nephrolithiasis, a combined approach: MALDI-TOF mass spectrometry and MicroBCA Protein Assay] 177
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 176
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 176
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 172
[Overactive bladder syndrome: the social and economic perspective] 171
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 170
Imaging in prostate cancer diagnosis: present role and future perspectives 169
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 163
Advanced bladder cancer: New agents and new approaches. A review 160
L' era del PCA3: risultati preliminari di uno studio pragmatico monocentrico 160
Microbiological follow-up of nosocomial infections in a single urological center 160
Brachytherapy in men with prostate cancer: update on indications and outcomes 159
Imaging of renal cell carcinoma: state of the art and recent advances 158
Imaging in prostate cancer staging: present role e future perspectives 156
Zinner syndrome: Two cases and review of the literature 155
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 154
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 150
Advanced bladder cancer: New agents and new approaches. A review 149
Imaging in prostate cancer staging: present role and future perspectives 146
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 145
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 145
Circumcision: history, religion and law 144
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 143
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 143
Inhibition of prostate efferent neurotransmission by amikacin 142
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 142
InTrathecal mORphine, traNsversus Abdominis Plane Block, and tramaDOl Infusion for Catheter-Related Bladder Discomfort in Patients Undergoing Robot-Assisted Laparoscopic Prostatectomy (TORNADO): A Pilot Prospective Controlled Study 139
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine 136
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 136
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 136
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 135
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 133
Imaging of renal cell carcinoma: state of the art and recent advances 133
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center 130
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations 129
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 125
Management of Iatrogenic Bladder Injury due to Vascular Surgery: Case Report and Literature Review 124
18F-Fluoroethylcholine PET/CT Radiomic Analysis for Newly Diagnosed Prostate Cancer Patients: A Monocentric Study 122
Imaging in prostate cancer diagnosis: present role and future perspectives 122
[Doping and urologic tumors] 122
The new surgical robotic platform HUGOTM RAS: System description and docking settings for robot-assisted radical prostatectomy 121
Depiction of periprostatic nerve fibers by means of 1.5 T diffusion tensor imaging 121
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging–Hystopatology correlations 117
Imaging of renal cell carcinoma: state of the art and recent advances. 108
Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation 108
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 105
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors 104
Robot-Assisted Radical Prostatectomy Performed with the Novel Hugo™ RAS System: A Systematic Review and Pooled Analysis of Surgical, Oncological, and Functional Outcomes 104
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging—Hystopatology correlations 103
Male sling placement for post-prostatectomy incontinence can involve a lengthy learning curve: A multi-outcome assessment via cumulative sum failure analysis 102
Rate of clinically significant prostate cancer on repeat saturation biopsy after a diagnosis of atypical small acinar proliferation 100
[Prostatitis syndromes and sporting activities] 99
Recovery from deep neuromuscular blockade using different sugammadex doses in elderly patients undergoing laparoscopic robot-assisted prostatectomy 98
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 97
ECG-gated CT angiography of the thoracic aorta: the importance of evaluating the coronary arteries 97
What can the metaverse do for urology? 96
Circumcision: history, religion and law 95
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 93
[Continuing evolution of statistical tests in medical research] 93
Relationship between Middle Cerebral Artery Pulsatility Index and Delayed Neurocognitive Recovery in Patients undergoing Robot-Assisted Laparoscopic Prostatectomy 92
[Androgen-deprivation therapy in prostate cancer: clinical evidence and future perspectives] 85
Purely Off-Clamp Partial Nephrectomy: Robotic Approach Better than Open Using a Pentafecta Outcome with Propensity Score Matching 84
Bladder tumor markers: A review of the literature 77
In vitro effect of amikacin on rat and human detrusor muscle contraction 67
Markers for Urological Malignancies 65
Imaging in bladder cancer: Present role and future perspectives 60
Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes 56
Social, economic, and health utility considerations in the treatment of overactive bladder 56
Metastasis to the renal hilum from malignant melanoma of the anterior trunk: An unusual finding 52
Liquid Biopsy in Non-Metastatic Prostate Cancer: Clinical Evidence and Future Directions 24
A novel comprehensive cancer genome profiling for non-metastatic prostate cancer: study protocol with FPG500 to detect actionable alterations representative of progressive disease 14
Liquid Biopsy in Non-Metastatic Prostate Cancer: Clinical Evidence and Future Directions 1
Totale 15.336
Categoria #
all - tutte 51.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.897


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022769 0 51 43 84 64 37 30 94 66 66 105 129
2022/20231.761 208 202 156 271 114 203 83 147 186 62 73 56
2023/20241.617 96 225 106 149 110 124 112 155 83 138 119 200
2024/20252.175 111 78 187 108 189 86 127 117 267 228 374 303
2025/20264.216 570 119 265 421 765 210 801 227 263 331 152 92
2026/20271.004 183 821 0 0 0 0 0 0 0 0 0 0
Totale 15.336